The role of cycloastragenol at the intersection of NRF2/ARE, telomerase, and proteasome activity
- 17 June 2022
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 188, 105-116
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Impaired Transcriptional Activity of Nrf2 in Age-Related Myocardial Oxidative Stress Is Reversible by Moderate Exercise TrainingPLOS ONE, 2012
- Telomerase expression in the mammalian heartThe FASEB Journal, 2012
- Human telomerase acts as a hTR-independent reverse transcriptase in mitochondriaNucleic Acids Research, 2011
- The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidenceAging Cell, 2011
- CHIP Promotes Human Telomerase Reverse Transcriptase Degradation and Negatively Regulates Telomerase ActivityJournal of Biological Chemistry, 2010
- Nuclear Erythroid Factor 2-mediated Proteasome Activation Delays Senescence in Human FibroblastsJournal of Biological Chemistry, 2010
- Update on the oxidative stress theory of aging: Does oxidative stress play a role in aging or healthy aging?Free Radical Biology and Medicine, 2010
- Proteasomes Can Degrade a Significant Proportion of Cellular Proteins Independent of UbiquitinationJournal of Molecular Biology, 2009
- Activation and inhibition of the proteasome by betulinic acid and its derivativesFEBS Letters, 2007